Home › Funds › LOEWS CORP › LAB
LOEWS CORP position in LAB
STANDARD BIOTOOLS INC · Industrials
LOEWS CORP reported holding 1,250,000 shares of LAB (STANDARD BIOTOOLS INC) in its Q3 2026 13F filing — a position valued at US$926K, representing 0.01% of its reported portfolio and ranking #24 among its reported holdings. LOEWS CORP has disclosed LAB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How LOEWS CORP's LAB position evolved
LOEWS CORP first disclosed a stake in LAB in Q2 2026 at 1,250,000 shares (US$1.0M). Across 2 filings, LOEWS CORP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 1,250,000 shares valued at US$926K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.25M | $1.03M | New |
| Q3 2026 | 1.25M | $925.75K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LAB and 13F data
LAB (STANDARD BIOTOOLS INC) is a Industrials company. 18 other funds we track also report a position in LAB — the largest reported positions include Casdin Capital (US$73.0M), MAK CAPITAL ONE LLC (US$23.7M), Long Focus Capital Management, LLC (US$18.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LAB
- Casdin Capital 88.78M sh · $73.04M · Q2 2026
- MAK CAPITAL ONE LLC 28.81M sh · $23.71M · Q2 2026
- Long Focus Capital Management, LLC 25.31M sh · $18.74M · Q3 2026
- Hollow Brook Wealth Management LLC 5.20M sh · $3.85M · Q3 2026
- Tikvah Management LLC 3.55M sh · $2.63M · Q3 2026
FAQ
How long has LOEWS CORP held LAB?
LOEWS CORP has disclosed LAB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is LOEWS CORP's current position in LAB?
As of Q3 2026, LOEWS CORP holds 1.25M shares of LAB (STANDARD BIOTOOLS INC), valued at $925.75K, representing 0.01% of its reported portfolio and ranking #24.
Has LOEWS CORP been buying or selling LAB?
In the latest 13F filing (Q3 2026), LOEWS CORP held unchanged its position in LAB.
Which other funds hold LAB?
Other major institutional holders of LAB include Casdin Capital, MAK CAPITAL ONE LLC, Long Focus Capital Management, LLC, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.